$NKTR news
The latest NKTR stock news: headlines, filings, AI summaries and sentiment for $NKTR, updated around the clock.
- Protagonist Therapeutics Reports Q3 Earnings Beat with Significant Revenue Growth
- Shattuck Labs Reports Q3 GAAP EPS Miss Amid Increased Cash Reserves
- Nektar Therapeutics Shares Drop After Mid-Stage Hair Loss Drug Data Release
- NEKTAR THERAPEUTICS - 8-K Filing
- Nektar Therapeutics Shares Rise After Jury Awards $90 Million Plus Interest Against Eli Lilly
- NEKTAR THERAPEUTICS - 8-K Filing
- Nektar Therapeutics Stock Drops Amid Jury Deliberation in Dispute with Eli Lilly
- NEKTAR THERAPEUTICS - 8-K Filing
- Nektar Therapeutics CEO Sells $1.2 Million Worth of Shares Amid Significant Stock Price Increase
- Prosight Management Invests $10.27 Million in Nektar Therapeutics Ahead of Key Phase 3 Launch
- Prosight Management Invests $10 Million in Nektar Therapeutics Ahead of Key Phase 3 Launch
- Patient Square Capital Acquires New Position in Nektar Therapeutics
- Patient Square Capital Acquires Stake in Nektar Therapeutics
- NEKTAR THERAPEUTICS - 8-K Filing
- NEKTAR THERAPEUTICS - 10-Q Filing
- Nektar Therapeutics Q1 2026 Earnings Call Summary
- NEKTAR THERAPEUTICS - 8-K Filing
- Nektar Therapeutics Investors Have Deadline to Join Securities Fraud Lawsuit
- Class Action Lawsuit Filed Against Nektar Therapeutics Over Alleged Misleading Statements
- Nektar Therapeutics Reports Positive Clinical Trial Results for Hair-Loss Drug
- Nektar Therapeutics Securities Fraud Lawsuit Allows Investors to Join Class Action
- Nektar Therapeutics Reports Positive Phase 2b Trial Results for Hair-Loss Drug, Driving Stock Higher
- Pomerantz Law Firm Files Class Action Against Nektar Therapeutics and Officers